Short answer · Medically reviewed summary · Last updated: 2026-05-08
Miller Fisher Syndrome (MFS) is a rare, acquired nerve disorder characterized by a clinical triad of ophthalmoplegia, ataxia, and areflexia. It is most commonly referred to as Miller Fisher Syndrome, though it is also recognized as a localized variant of Guillain-Barré Syndrome (GBS) and is occasionally documented as Fisher Syndrome in medical literature. What are the common synonyms and abbreviations for Miller Fisher Syndrome? While Miller Fisher Syndrome is the standard medical term, you may encounter several variations in clinical records or older literature.
Miller Fisher Syndrome synonyms
Other names for Miller Fisher Syndrome: synonyms, acronyms and related terms used by doctors and patients.
Miller Fisher Syndrome (MFS) is a rare, acquired nerve disorder characterized by a clinical triad of ophthalmoplegia, ataxia, and areflexia. It is most commonly referred to as Miller Fisher Syndrome, though it is also recognized as a localized variant of Guillain-Barré Syndrome (GBS) and is occasionally documented as Fisher Syndrome in medical literature.
What are the common synonyms and abbreviations for Miller Fisher Syndrome?
While Miller Fisher Syndrome is the standard medical term, you may encounter several variations in clinical records or older literature. These synonyms often reflect the condition's classification as a variant of the broader autoimmune spectrum of polyneuropathies. Common names include:
- Fisher Syndrome (a shortened, common clinical eponym)
- Fisher’s Syndrome
- MFS (the standard medical abbreviation)
- Miller Fisher Variant of Guillain-Barré Syndrome
- Acute Ophthalmoplegia-Ataxia-Areflexia Syndrome (a descriptive clinical term)
Why are there multiple names for this condition?
The naming of Miller Fisher Syndrome has evolved alongside our understanding of its pathology. Originally described by Dr. Charles Miller Fisher in 1956, it was identified as a distinct clinical entity. As medical research progressed, clinical geneticists and neurologists reclassified Miller Fisher Syndrome as a localized, cranial nerve variant of Guillain-Barré Syndrome. The presence of anti-GQ1b ganglioside antibodies is now a key diagnostic marker that links Miller Fisher Syndrome to other related conditions, such as Bickerstaff brainstem encephalitis.
What is the official classification of Miller Fisher Syndrome?
In international medical coding and classification systems, consistency is essential for research and patient care. Miller Fisher Syndrome is categorized under the following official references:
- ICD-10: Classified under G61.0 (Guillain-Barré syndrome), as it is a recognized variant.
- Orphanet: Listed as ORPHA:3335, specifically categorized under the umbrella of acute inflammatory polyneuropathy.
- OMIM: Documented under the entry #617300, focusing on the genetic and autoimmune susceptibility factors.
Next steps
- Consult a board-certified neurologist if you suspect symptoms of Miller Fisher Syndrome, particularly if you experience sudden vision changes or balance issues.
- Connect with the 36 community members on DiseaseMaps.org to share experiences and find support.
- Request a referral for anti-GQ1b antibody testing to assist in definitive diagnosis.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.
References
- Orphanet (ORPHA:3335): Miller Fisher Syndrome.
- NIH GARD (Genetic and Rare Diseases Information Center): Miller Fisher Syndrome.
- OMIM (Online Mendelian Inheritance in Man): #617300.
- GBS/CIDP Foundation International: Resources on Miller Fisher Syndrome variants.
